Kristin G Anderson

9PUBLICATIONS
63CO-AUTHORS
Cancer cell biologyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 23, 2026
Opportunities to enhance cancer research through advocate-researcher partnerships.

|Sep 22, 2025
Triple checkpoint blockade of PD-1, Tim-3, and Lag-3 enhances adoptive T cell immunotherapy in a mouse model of ovarian cancer.

Gabriel F Alencar, Asmaa O Mohamed, Madison G Burnett

|Aug 25, 2025
Neoadjuvant PD-1 blockade: a new treatment option for patients with early-stage mismatch repair deficient solid tumors.

Kristin G Anderson, Antoni Ribas

|Oct 31, 2023
Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium.

Christopher Alvarez-Breckenridge, Kristin G Anderson, Ana Luisa Correia

|Jul 03, 2023
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies.

Kristin G Anderson, David A Braun, Aitziber Buqué

|Mar 10, 2022
Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy.

Kristin G Anderson, Shannon K Oda, Breanna M Bates

Pageof 2

Frequent Collaborators

2 joint publications

Valentin Voillet

2 joint publications

Madison G Burnett

2 joint publications

Abigail Overacre-Delgoffe

2 joint publications

Jennifer L Guerriero